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Summary
The Tat protein and the transactivation responsive
(TAR) RNA form an essential complex in the HIV life-
cycle, and mutations in the basic region of the Tat
protein alter this RNA-protein molecular recognition.
Here, EPR spectroscopy was used to identify amino
acids, flanking an essential arginine of the Tat pro-
tein, which contribute to specific and rigid TAR-Tat
complex formation by monitoring changes in the mo-
bility of nitroxide spin-labeled TAR RNA nucleotides
upon binding. Arginine to lysine N-terminal mutations
did not affect TAR RNA interfacial dynamics. In con-
trast, C-terminal point mutations, R56 in particular, af-
fected the mobility of nucleotides U23 and U38, which
are involved in a base-triple interaction in the com-
plex. This report highlights the role of dynamics in
specific molecular complex formation and demon-
strates the ability of EPR spectroscopy to study in-
terfacial dynamics of macromolecular complexes.
Introduction
The transactivation responsive (TAR) RNA is the 5#-
leader sequence of the HIV-1 mRNA genome and in-
teracts with the Tat protein during transcription [1]. TAR
and Tat bind to cyclin T1 (CycT1) and cyclin-dependent
kinase 9 (CDK9) as part of the positive transcription
elongation factor (P-TEFb) complex to counter the ef-
fect of negative elongation factors [2] and promote effi-
cient transcription of the full-length HIV genome [3]. In
the absence of the TAR-Tat interaction, viral transcrip-
tion is inefficient [4], which makes the TAR RNA-Tat pro-
tein complex an important target for therapeutic inter-
vention of HIV replication [5, 6].
A duplex stem containing a trinucleotide bulge has
been identified as the Tat binding region of the TAR
RNA (Figure 1A) by numerous studies utilizing electro-
phoretic mobility shift assays to examine the effect of
RNA mutagenesis on complex formation [7–12]. The
basic domain of the Tat protein spanning residues 47–
57 has been identified as the TAR RNA binding region
in a similar manner [7, 8, 13, 14]. In particular, arginine
52 (R52) has been identified as a critical amino acid for
TAR-Tat complex formation [15–17]. Mutation of several
residues flanking R52 to lysine resulted in minimal loss*Correspondence: snorrisi@hi.isof either binding affinity for short Tat-derived peptides
[15, 17, 18] or transactivation activity for the full Tat pro-
tein [14, 15, 17, 18], signifying that only R52 is essential
for complex formation.
Despite extensive efforts, a high-resolution structure
of the HIV TAR-Tat complex has not been obtained.
However, the NMR solution structures of the TAR RNA
[19] and the Tat protein [20–22] have been solved indi-
vidually. Several NMR studies have investigated the
TAR RNA structural change that takes place upon bind-
ing to derivatives of the Tat protein such as arginine
[23, 24], argininamide [25–28] or Tat-derived peptides
[19, 29]. These studies have revealed two levels of mo-
lecular recognition that include specific and nonspe-
cific complex formation [29]. In particular, imino proton
NMR spectroscopic data indicated that a specific com-
plex was formed in the presence of the wild-type pep-
tide containing the core sequence RKKRRQRRR (resi-
dues 49–57), whereas the markers for specific complex
formation were absent in the presence of a mutant pep-
tide containing the core sequence RKKRKQKKK [29].
Incorporation of nitroxide spin-labels enables investi-
gation of internal motions and ligand-induced confor-
mational changes using electron paramagnetic reso-
nance (EPR) spectroscopy [30–33]. Recently, we used
EPR spectroscopy to examine the binding of argininam-
ide, a mutant Tat-derived peptide (YKKKKRKKKKA), and
a wild-type peptide (YGRKKRRQRRR, residues 47–57)
to nitroxide spin-labeled TAR RNAs [34]. As expected,
similar overall changes in RNA internal dynamics were
observed for the three Tat derivatives upon complex
formation, indicating similar structural changes in the
RNA upon binding. However, significantly larger de-
creases in mobility at U23 and U38 were observed in
the presence of the wild-type peptide in comparison
with argininamide or mutant peptide binding. Hence,
both EPR and NMR spectroscopy [29] indicate that in
addition to arginine 52, amino acids present in the wild-
type peptide that are not present in the mutant peptide
are responsible for the increased specificity in molecu-
lar recognition.
Although there is substantial evidence for the partici-
pation of the amino acids flanking the essential arginine
52 in formation of the rigid complex, the structural role
of individual amino acids in the flanking regions has not
been identified. One reason is that it is not possible
to measure the contribution of individual amino acids
toward TAR-Tat complex formation by traditional muta-
genesis and binding assays due to the similar binding
affinities of the mutant and wild-type Tat-derived pep-
tides. It is possible to use solution NMR spectroscopy
of isotopically labeled RNA, but screening individual
amino acids would be costly and labor intensive. In
contrast, EPR spectroscopy only requires small quanti-
ties of material (0.1–2 nmol per sample), has short data
acquisition times (typically 1–2 hr per sample), and is
sensitive to variations in RNA structure and internal dy-
namics upon binding to different ligands [35, 36].
Therefore, EPR spectroscopy of site specifically spin-
labeled RNA offers an efficient method for identifying
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330Figure 1. Applying EPR Spectroscopy to the TAR RNA
(A) Construct of the TAR RNA used in this study with spin-labeling sites indicated in bold.
(B) Preparation of spin-labeled RNA.
(C) EPR spectrum of U23 TAR in the absence of peptide with EPR spectral width (2Azz) and centerline width (δ) indicated.amino acids responsible for rigid RNA-protein com- m
oplex formation.
aHere, we describe the use of EPR spectroscopy to
idetermine which amino acids in the basic region of the
5Tat protein are responsible for the observed decreases
tin U23 and U38 mobility in the wild-type TAR RNA-Tat
wpeptide complex. Changes in nitroxide spin-label mo-
cbility, which have been shown to correlate with differ-
aences in nucleotide mobility [37], were investigated at
tfour RNA sites upon incubation with a series of Tat-
dderived mutant peptides. Our results indicate that mu-
ltations in the C-terminal end of the Tat basic region,
Ubut not the N-terminal end, interfere with wild-type RNA
[dynamics in the TAR-Tat complex, and that specifically,
targinine 56 most prominently contributes to U38 immo-
mbilization. These results are presented in the context of
aknown structural and transcriptional data.
w
3
tResults
t
Experimental Design
ERecently, we developed a general and efficient method
Tto site specifically incorporate nitroxide spin-labels into
snucleic acids [37] in order to facilitate the study of li-
gand-induced RNA conformational changes by EPR
spectroscopy [33–36, 38–40] in a manner analogous to
studies currently being performed for proteins [41–44].
Four TAR RNAs were prepared such that each con-
tained a nitroxide spin-labeled nucleoside within the Tat
binding region (Figure 1). We previously showed that
spin-labels at these sites have little effect on TAR-Tat
binding affinity by native gel electrophoresis [34]. In ad-
dition, titration of the Tat wild-type peptide to U40 spin-
labeled RNA revealed changes in the EPR spectral
width up to 1 equivalent of peptide (0.2 mM), after
which no further changes were observed until line
broadening was observed at 0.7 mM concentration of
peptide. These results indicate complete and specific
binding at the lower peptide concentrations, but non-
F
specific binding or aggregation at higher peptide con-
M
centrations [34]. In the current study, a series of pep- d
tides were designed to test the influence of amino acids
in the basic region of the Tat protein on rigid TAR-Tatolecular recognition (Figure 2). Given the sequences
f the wild-type and Tat I peptides, candidate amino
cids that could provide the observed increase in spec-
ficity [34] are glycine 48, arginines 49, 53, 55, 56, and
7 and glutamine 54. Peptide II was designed to test
he influence of residues on the N-terminal end,
hereas peptides III and IV were designed to test the
ontribution of amino acids on the C-terminal end. In
ddition, peptides V, VI, VII, and VIII were prepared to
est the influence of single arginines at C-terminal resi-
ues 53, 55, 56, and 57, respectively, by mutation to
ysine. In the presence of these peptides, changes in
25 mobility were similar to those previously observed
34] showing TAR-Tat complex formation with the mu-
ant peptides (Figure 3). In addition, changes in U40
obility were also consistent with previous results [34],
lthough peptides II–VIII resulted in increased spectral
idth (2–5 G) relative to the wild-type peptide (Figure
). However, no clear trends emerged among these mu-
ants, and thus these minor differences were not inves-
igated further.
PR Spectral Analysis
ypically, three types of motion can be studied by EPR
pectroscopy [32]. First, the probe can move indepen-igure 2. Sequence Analysis of Tat Protein Derivatives
ultiple sequence alignment of wild-type HIV-1 protein; the Tat-
erived peptides used by Long and Crothers, Tfr24 and R52 [29];and the Tat-derived peptides used for the EPR spectroscopic
studies.
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331Figure 3. U25 and U40 EPR Spectroscopy of
TAR RNA-Tat Peptide Complexes
Changes in EPR spectral width (2Azz in
gauss, G) of U25 or U40 spin-labeled TAR
RNA upon binding to derivatives of the Tat pro-
tein. The approximate error in the spectral
width is 0.3 G. Spectra were obtained at 0°C
in 20% sucrose/100 mM NaCl, 10 mM sodium
phosphate, and 0.1 mM Na2EDTA (pH 7.0).dent of the macromolecule. For the current study, we
employed a semiflexible ureido tether, designed to min-
imize the motions of the probe independent of the nu-
cleic acid [37]. Second, the global motion, arising from
either the tumbling of the whole macromolecule or mo-
tions of its individual domains relative to one another
can be detected. The global motion can often be elimi-
nated by addition of sucrose to the solution; here, ex-
perimental conditions were selected to contain 20%
sucrose, which largely eliminates the global motions of
the macromolecular complex. The third type of motion
is the local motion, which in our case would be the mo-
tion of the nucleotide to which the probe is attached.
Although steps have been taken to minimize the first
two types of motion to allow us to study the local mo-
tion of the TAR RNA, a component of the overall ob-
served motion probably originates from movement of
the probe independent of the nucleic acid and/or
movement of individual domains within the RNA or
RNA-protein complex.
Incorporation of a nitroxide spin-label via a 2#-ureido
linkage allows for the detection of structure-dependent
dynamics by EPR spectroscopy [37]. Specifically, ni-
troxides located at flexible positions such as U23 and
U25 exhibit narrower spectral widths, which correlate
with increased motion of the nitroxide spin-probe [45],
relative to those in base-paired sites (U38 and U40) [37].
For the current study, changes in EPR spectral width
(2Azz) upon complex formation were plotted for each
nucleotide as a function of peptide mutation, thus
showing increased or decreased nucleotide mobility
relative to the unbound TAR RNA (Figures 3–5). Alterna-
tively, nitroxide motions can be monitored by determin-
ing the effective local rotational correlation times (τR)
according to the S method [45], or by calculating the
scaled relative mobility factor (Ms), which provides a
simple semiquantitative measure of the nitroxide mobil-
ity [32] (see Supplemental Data for calculations). For
each EPR spectrum presented here, values for all
spectral parameters (2Azz, τR, and Ms) are presented in
the Supplemental Data; for the current study 2Azz
ranged from 50.5 to 72.0 G, with an error of ±0.3 G; τR
ranged from 2.4 to 27.4 ns, with a typical error of ±0.2
ns; Ms ranged from 0.04 to 0.53, with a typical error of
±0.04 arbitrary units. These parameters for semiquanti-
tative determination of nitroxide mobility provide es-
sentially the same type of information; for example,plotting Ms as a function of peptide mutation (Supple-
mental Data) gives the same information as that pre-
sented in Figures 3–5. Thus the same conclusions are
reached by monitoring the changes in the EPR spec-
tral width (2Azz) as from the S method or the scaled
relative mobility factor (Ms). In this paper, we present
our results using the EPR spectral width to monitor
changes in TAR RNA nucleotide dynamics.
Mutations that Affect U23 TAR RNA
Internal Dynamics
The wild-type Tat peptide induced large changes in the
EPR spectrum of U23 TAR RNA (2Azz = +12.5 G, τR =
6.1 ns, and Ms = 0.29), whereas Tat peptide I induced
small changes (2Azz = +0.8 G, τR = 2.6 ns, and Ms =
0.48) relative to U23 TAR in the unbound state (2Azz =
50.5 G, τR = 2.4 ns, and Ms = 0.53) [34]. As the EPR
spectra in Figure 4 suggest, N-terminal mutations (pep-
tide II) do not alter U23 dynamics relative to the native
state. Multiple C-terminal amino acid deletions (III) or
mutations (IV) moderately increase the mobility of U23
relative to the native state. On the other hand, individual
C-terminal mutations induce small increases in U23
mobility, most notably at positions R53 (V), R55 (VI), and
R56 (VII), although no difference was observed at posi-
tion R57 (VII). Overall, mutations in the C-terminal end
of the Tat peptide basic region change U23 internal dy-
namics to intermediate dynamic states, relative to the
U23 dynamics observed for peptide I and the wild-
type peptide.
Mutations that Affect U38 TAR RNA
Internal Dynamics
The dynamics of U38 in the free TAR RNA closely re-
semble that of a typical base-paired residue in a du-
plex, as evident by nearly superimposable EPR spectra
in comparison with U38 in a version of the TAR RNA
lacking a trinucleotide bulge (i.e., a simple 12 base-pair
duplex stem exactly complementary to the U38 strand;
data not shown). The U38 TAR RNA dynamics are sig-
nificantly decreased relative to the dynamics observed
in flexible regions, with a correlation time similar to that
estimated for the TAR RNA-peptide complex [37]. In
comparison with Tat peptide I (2Azz = +0.4 G, τR = 2.7
ns, and Ms = 0.38), U38 is extremely rigid in the pres-
ence of the wild-type peptide (2A = +19.8 G, τ =zz R
27.4 ns, and Ms = 0.04) and displays dynamics similar
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332Figure 4. U23 EPR Spectroscopy of TAR
RNA-Tat Peptide Complexes
EPR spectra of U23 and changes in EPR
spectral width (2Azz in gauss, G) in the pres-
ence of Tat-derived peptides. The dotted
lines indicate the spectral width of U23 in the
presence of the wild-type (wt) peptide and
are extended through the other spectra for
visual comparison.N-terminal side of R52 to lysine (IV). Individual lysine (Figure 5). On first inspection, the two states closely
Figure 5. U38 EPR Spectroscopy of TAR
RNA-Tat Peptide Complexes
EPR spectra of U38 and changes in EPR
spectral width (2Azz in gauss, G) in the pres-
ence of Tat-derived peptides. The dotted
lines indicate the spectral width of U38 in the
presence of the wild-type (wt) peptide and
are extended through the other spectra for
visual comparison.to the expected global dynamics of the complex [34]. r
iMutation of G48 and R49 to lysine in the N-terminal
end of the Tat protein basic region did not affect U38 t
mdynamics in the TAR-Tat complex (peptide II, Figure 5).
Removal of the three C-terminal arginine residues (55– o
(57, peptide III) produced EPR spectra and hence nitrox-
ide dynamics similar to that observed for the mutant
V(I) state, as did mutation of the five residues on theeplacement mutation at R53 (V), R55 (VI), or R57 (VII)
ncreased U38 internal dynamics relative to the wild-
ype peptide. Much more dramatic was the observed
utation of R56 to lysine, which changed the mobility
f the U38 spin-label to a degree similar to peptide I
2Azz = +2.2 G, τR = 3.0 ns, and Ms = 0.26).
The U38 spectra in the presence of mutant peptides
, VI, VII, and VIII appear to contain two components
EPR Spectroscopy of TAR RNA-Tat Protein Complex
333resemble the rigid complex observed in the presence
of the wild-type peptide and the flexible state obtained
for the complex with peptide I. We tested this observa-
tion by developing a least squares optimization to fit
these spectra to a two-component system containing
the wild-type peptide and mutant I peptide samples as
component spectra. Component spectra were summed
to give the best least squares fit to the entire composite
spectra. Excellent fits were obtained for peptides V and
VI, as judged by the composite and difference spectra
(Figure 6). The fraction of rigid component for peptide
V was 68% ± 4% and the fraction of rigid component
for peptide VI was 39% ± 19%. The high error rate in
the fitting for peptide VI was largely due to a free spin
component in this mixture. If this free spin component
is disregarded, as is commonly done by spectral
subtraction, the fit is excellent. The fits for VII and VIII
were poor, especially in the high and low field extremes,
where the line width is most sensitive to changes in
dynamics; therefore, it is likely that these spectra do
not represent a simple composite of the two compo-
nents investigated.
Alternatively, the fractions of each component were
determined using a simple algebraic solution based onFigure 6. Spectral Fittings of U38 Multicomponent EPR Spectra
Spectral fitting of U38 EPR spectra in the presence of Tat-derived
peptides V (A) and VI (B); the black spectra are the experimental
spectra, the magenta spectra are the composite spectra, and the
cyan spectra are the difference spectra.the centerline width of the mutant I peptide (δ = 3.92 G)
and the wild-type peptide (δ = 7.58 G), assuming a two
state model. Using this method, which is naturally bi-
ased toward the more mobile component and is, there-
fore, less accurate than the method presented above,
the following percentages of rigid component were ob-
tained for each peptide: V, 50%; VI, 37%; VII, 22%; and
VIII, 38%. Although the fittings were poor for peptide
VII and VIII, the combined results of the crude fittings
and algebraic solutions give a rough estimate of the
percentages of rigid and mobile components in each,
even if the individual components do not correspond
well with the wild-type peptide and Tat peptide I.
Discussion
RNA-protein interactions play important roles through-
out biological systems. Although several RNA-protein
structures have been solved by NMR spectroscopy and
X-ray crystallography, few studies have focused on the
recognition dynamics of RNA-protein interfaces. NMR
spectroscopy of ribosomal protein-rRNA, U1A-RNA,
and Stuafen protein-RNA complexes (reviewed in [46])
as well as fluorescence correlation spectroscopy of the
N protein-boxB interaction from bacteriophage lambda
[47] have demonstrated the functional importance of RNA
dynamics in RNA-protein complex assembly. Here, we
present the use of EPR spectroscopy to study the in-
terfacial dynamics of the HIV-1 TAR RNA-Tat protein
complex and use observed differences in dynamics to
identify which amino acids in the Tat protein contribute
to RNA rigidity in the native RNA-protein complex.
The accumulation of a large field of literature investi-
gating the HIV-1 TAR RNA-Tat protein interaction has
revealed two levels of specificity in the RNA-protein
molecular recognition. At the first level, the TAR RNA
forms a binding pocket around a single essential argi-
nine at position 52, as evidenced by NMR solution
structures of the TAR RNA bound to arginine-based
small molecules [23, 24, 26, 27, 48]. This arginine coor-
dinates U23, which forms a base triple with A27 and
U38, and stacks on A22 and along G26 while interacting
with phosphates 21 and 22. TAR-arginine complex for-
mation induces a global RNA structural change [28, 49]
and alters the internal dynamics of the nucleotides sur-
rounding the binding region of the TAR RNA [34, 50]. At
this level of specificity, the changes in nucleotide mobil-
ity observed by EPR spectroscopy of the TAR-arginin-
amide complex [34] are generally in agreement in direc-
tion and relative magnitude with changes observed by
NMR spectroscopy [50]. We denote this level of speci-
ficity the flexible level, given the relative mobility of the
nucleotides [34, 50].
In the second level of molecular recognition, amino
acids flanking the essential arginine contribute to the
specificity of the interaction. This is manifested, for ex-
ample, in moderate effects on the transcription rates
(up to 3-fold [15]). Furthermore, the flanking amino
acids influence the interfacial dynamics and positioning
of the TAR nucleotides as observed by NMR [25, 29]
and EPR spectroscopy [34], particularly of U23 and
U38, which are involved in a base-triple interaction that
is a key feature of TAR-Tat recognition. For example, in
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g2), NMR analysis revealed U23 and U38 imino reso-
nances that were either missing (U23) or at a different c
dchemical shift (U38) in the presence of the mutant pep-
tide (“R52,” Figure 2) [29]. In addition, EPR spectros-
fcopy revealed large changes in U23 and U38 dynamics
in the presence of the wild-type peptide (Tat wt, Figure w
p2), but small changes in the presence of a mutant pep-
tide (I, Figure 2) [34]. Together, the NMR and EPR data p
3indicate large changes in the spectroscopic properties
of nucleotides U23 and U38 in the presence of the wild- o
ttype peptide compared to the TAR RNA in the presence
of the Tat mutant peptide. In agreement with the bio- b
tphysical data, kinetic dissociation data indicated mono-
phasic kinetics for the wild-type peptide, but biphasic t
1kinetics for the mutant peptide, providing further evi-
dence that these peptides bind differently to the TAR m
tRNA [51]. We refer to this level of specificity as the rigid
level, due to the substantial decreases in U23 and s
aU38 mobility.
The series of Tat-derived peptides studied here (Fig- w
lure 2) induced similar changes in mobility with only
minor variation at positions U25 and U40 (Figure 3), t
ssubstantial changes in mobility with moderate sensi-
tivity to Tat amino acid modification at U23 (Figure 4), p
sand substantial changes in mobility with high sensitiv-
ity at U38 (Figure 5). Neither U23 nor U38 is sensitive to p
qN-terminal peptide mutation at glycine 48 or arginine
49 (peptide II), and these amino acids are likely not in- m
tvolved in formation of the specific and rigid complex.
In contrast, dramatic effects are seen in peptides con- p
ltaining mutation(s) in the C-terminal end. Our results
show that single arginine to lysine mutation at either R
fR53 (V), R55 (VI), or R56 (VII) increased the mobility of
both U23 and U38 relative to the rigid wild-type state o
t(Figures 4 and 5). The most striking result was observed
upon mutation at R56, which increased the internal dy- f
tnamics of U38 nearly 10-fold, relative to the effect of
the wild-type peptide. Thus, the R56 mutation yielded a
ca spectrum similar to that obtained for the Tat peptide
I, indicating that R56 forms key contacts in the rigid i
nwild-type complex. Although we describe these changes
in dynamics as local effects, we cannot rule out the w
tpossibility that some of the observed changes in mo-
tion arise from movement of the probe independent of r
mthe RNA or from global motions of individual domains.
Regardless of the source of these motions, however, v
tthe RNA dynamics can be used as a structural indicator
to identify specific amino acids that are important for c
athe RNA-protein complex formation.
Inspection of the U38 EPR spectra reveals that pep- a
tides V and VI contain a flexible and a rigid component,
each of which has similar features to peptide I and the T
swild-type peptide, respectively (Figure 5). In fact, the
individual spectra for peptide I and the wild-type pep- t
stide can be summed to produce an excellent fit (Figure
6). For peptide V, w70% of the sample is in the rigid c
Ncomplex andw40% for peptide VI. The U38 spectra of
peptides VII and VIII seem to contain a rigid and a flexi- a
tble component; however, the fittings for these spectra
were poor, indicating that these samples do not contain f
fa simple mixture of the flexible and the rigid complex
as was observed for peptides V and VI, but that pep- t
mtides VII and VIII adopt more complex structures andynamics. Combined, these results indicate that the ar-
inines in the C-terminal region are important for rigid
omplex formation and that they act in concert to pro-
uce a rigid TAR-Tat complex.
The EPR spectroscopic results concerning rigid and
lexible complex formation correlate reasonably well
ith data on transcriptional activation rates. Single
oint mutations throughout the basic region of the Tat
rotein only affect transcription activation rates up to
-fold [14, 15, 17, 18], which led to the conclusion that
verall charge density of the basic region was impor-
ant, but that specific residues were not essential for
inding [18]. On the other hand, multiple point muta-
ions lead to severe decreases in transcriptional activa-
ion in comparison with the wild-type protein [14, 17,
8]. Therefore, it was concluded that arginine 52 was
ost important for binding based on an arginine walk
hrough a poly-lysine peptide [15]. From the EPR re-
ults presented above, single point mutations at 53, 55,
nd 56 produced small increases in the mobility of U23,
hereas multiple point mutations at these positions
argely perturbed the native state dynamics; both of
hese results are in agreement with results from tran-
cription activation studies. For U38 dynamics, single
oint mutations at 53 (V) and 55 (VI) produced a two
tate equilibrium between the flexible and rigid com-
lex (Figure 6). If formation of the rigid complex is re-
uired for high-fidelity transcription activation, one
ight not expect a large effect of arginine to lysine mu-
ations at positions 53 and 55, because a substantial
art of the complex can access the rigid state. The
argest change in U38 dynamics was observed for the
56K mutation (VII), which predominantly produced the
lexible state. However, some spectral broadening was
bserved, indicating a less flexible component, al-
hough simulation to a two state model between the
lexible and the rigid state did not give a good fit to
he experimental data. Double mutation of both amino
cids 55 and 56 to alanine [18] or glutamine [14] drasti-
ally reduced transcription activation (at least 15-fold
n each case); however, mutation to lysine had virtually
o effect on transcription activation [18]. Therefore, it
ould appear that the EPR results for U38, which show
he strongest effect for the R56K mutation, do not di-
ectly corroborate the transcription studies. However,
ore recent studies in which peptides were selected in
itro to bind to the TAR RNA have revealed that pep-
ides with an arginine residue at position 56 appear to
onsistently perform 2- to 3-fold better in transcription
ctivation studies than peptides with lysine or another
mino acid at this position [52, 53].
In the absence of a high-resolution structure for the
AR-Tat complex, one can only speculate about the
tructural origin of the dramatic effect that R56K has on
he dynamics of U38. However, inspection of the NMR
olution structures of the Tat protein [20–22] provides
lues about the structural origins of this effect. The
MR Tat structures show some structural variation, but
ll demonstrate that the basic region forms one face of
he protein surface (Figure 7). More specifically, this
ace spans residues 52–57, suggesting that these might
orm an RNA binding surface; furthermore, this struc-
ural element supports the observation that the N-ter-
inal residues 48 and 49 do not contribute to rigid
EPR Spectroscopy of TAR RNA-Tat Protein Complex
335Figure 7. TAR RNA Molecular Recognition
Surface of the Tat Protein
MOLMOL views of Tat protein (pdb file 1TIV
[20]) demonstrating that the basic region of
the Tat protein forms a binding surface for
the TAR RNA. Residues 52–57, which were
identified here through EPR spectroscopy as
important for the RNA-protein interfacial dy-
namics, are shown in green and form a sin-
gle face of the binding surface. Residues 48–
51, which were shown here to not affect TAR
RNA interfacial dynamics, are shown in gold.complex formation. More importantly, arginines 52 and
56 protrude into solution from the same side of the
binding surface and likely form a platform for TAR RNA
recognition. This observation, which indicates the im-
portance of these residues for interfacial dynamics,
provides indirect support for the EPR data identifying
the importance of R56 in formation of the rigid com-
plex. However, the final proof will be provided only by
a high-resolution structure of the complex.
Significance
EPR spectroscopy was used to identify which amino
acids in the basic region of the Tat protein are respon-
sible for rigid TAR RNA-Tat protein molecular recogni-
tion. To our knowledge, this is the first example of
using changes in RNA dynamics to investigate struc-
tural requirements for an RNA binding protein by
EPR. Our results suggest arginines 52 and 56 were
most important for rigid TAR-Tat complex formation,
while the other C-terminal arginines 53, 55, and 57
contribute to specific binding to a lesser extent. In
contrast, N-terminal residues were not important for
complex formation. Furthermore, the results indi-
cated that the overall TAR-Tat structure switched be-
tween a rigid state and a flexible state for complexes
containing one of several C-terminal single point mu-
tants. These results show the importance of specific
contacts in the formation of a specific and rigid struc-
ture and provide further support for an induced-fit
mechanism in the TAR RNA-Tat protein complex for-
mation. This study highlights the utility of EPR
spectroscopy for identifying critical residues in the
formation of dynamic macromolecular complexes.
Experimental Procedures
Preparation of RNA
Unmodified and 2#-NH2-modified RNAs were purchased from
Dharmacon Research, Inc (Lafayette, CO). Spin-labeled RNAs were
prepared as previously described by reaction of 4-isocyanato
TEMPO with 2#-NH2-modified RNA (Figure 1), followed by denatur-
ing polyacrylamide gel purification [34, 37].Purification of Tat-Derived Peptides
Peptides were purchased from United Biochemical Research, Inc.
(Seattle, WA) and characterized by MALDI-TOF mass spectrometry.
For EPR spectroscopy, small quantities (1–5 mg) were purified by
RP-HPLC on a Beckman 421A HPLC using a Dynamax Rainin
300 Å 25 × 250 mm preparatory 5 m C18 column. Sample elution
was monitored by dual wavelength UV at 220 and 275 nm. Solvent
gradients were run at 10 ml/min as follows: solvent A, 0.1% aq
trifluoroacetic acid (TFA); solvent B, CH3CN; 40-min linear gradient
from 0% B to 50% B, 5 min linear gradient to 0% B. Collected
samples were lyophilized to dryness and then dissolved in sterile
water and quantified by UV spectroscopy at A275 ( = 1420 l ·
mol–1 · cm–1). It is critical to lyophilize the peptides to dryness;
simple drying in a centrifuge in vacuo was insufficient to remove
excess TFA, which subsequently denatured the RNA upon resus-
pension of the peptide solution and incubation with the TAR RNA.
EPR Spectroscopy
For CW-EPR, 2.0 nmol of spin-labeled RNA and 2.8 nmol of unmod-
ified complement strand were incubated in 7.0 µl of 20% (w/v)
aqueous sucrose/100 mM NaCl, 10 mM sodium phosphate, and 0.1
mM Na2EDTA (pH 7.0) on a thermal cycler at 90°C for 2 min, 60°C
for 5 min, 50°C for 5 min, 40°C for 5 min, and 22°C for 15 min. Tat-
derived peptides in the above 20% aqueous sucrose phosphate
buffer (3.0 l) were then added to the above sample (final concen-
trations: 0.2 mM spin-labeled RNA, 0.5 mM peptide). RNA line sam-
ples were obtained in 0.8 × 1.0 mm quartz capillary (VitroCom, Inc.)
and stored at 4°C between experiments. X-band (9.3 GHz) CW-EPR
spectra were digitally recorded on a Bruker 300 EMX spectrometer
equipped with a TE102 cavity. Samples were obtained at 273.2 ± 0.2
K. Experimental parameters included 3355 G center field, 100 kHz
frequency modulation, 1.0 G modulation amplitude, 8 mW power,
20.48 ms time constant, 40.96 ms conversion, 1024 points, sweep
time 42 s, and 110 G sweep width. Typically 100–300 scans were
collected; the exact number depended on the signal to noise ratio,
which was observed to be inversely proportional to the EPR spec-
troscopic width.
EPR Spectroscopic Analysis
EPR spectral widths (2Azz) were measured directly from the spectra
in WIN-EPR and span the crest of the low field peak (i.e., the outer-
most point where the slope of the spectrum isw0) to the trough of
the high field peak with an error between sample preparations as
well as the measurement itself of 0.3 G (Figure 3). Spectra were
further analyzed using MATLAB. The extent to which the rigid and
flexible components were present in several multicomponent EPR
spectra was determined by least squares optimization of the fit
from the two component spectra. The spectra for the wild-type and
mutant I peptides were used as the component spectra, and the
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336sum of the component spectra yielded a composite spectrum. 1
Prior to summation, the individual component spectra were nor-
malized to a unit area so that the coefficients could be interpreted
in terms of fractional contribution to the composite spectra; to
properly normalize the EPR spectra, the component spectra were
scaled so that the double integral of each was unity. In addition to
1optimizing the coefficients of each component, the relative regis-
tration of each component on the abscissa with respect to the
composite spectrum was allowed to vary. In practice, the amount
that the spectrum was shifted along the x axis was never more than
3 Gauss.
1
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